Founded in 2009, JYMed is a pharmaceutical enterprise in China that integrates R&D,manufacturing,commercialization,and custom development and manufacturing of peptide products. The company has approximately 570 employees, with a core management team composed of professionals with pharmaceutical expertise and over 20 years of experience in the peptide industry. JYMed operates one research center and two major production facilities, achieving multi-ton scale production capacity in peptides, positioning it as an industry leader.
Introduction of JYMed peptide manufacturer, a US FDA inspection manufacturer. Featured products:Cosemtic peptide, Peptide APIs, Custom peptides. Such as, semaglutide, liraglutide, Tirzepatide, oxytocin, GHK, GHK-CU, Acetyl Hexapeptide-8.etc. If you want to konw more, please contact
email:jymed@jymedtech.com
JUST FOR BETTER PEPTIDES
healthy life
Innovative thinking
precision marketing
people-oriented and scientific and technological innovation